Navigation Links
AbbVie To Present Investigational Data From Phase II Hepatitis C Program At The Liver Meeting
Date:10/1/2013

011) were used in this analysis.

The list of accepted abstracts for The Liver Meeting can be accessed on www.aasld.org.

ABT-450 was discovered during the course of the ongoing collaboration between AbbVie and Enanta Pharmaceuticals for HCV protease inhibitors and regimens that include protease inhibitors. ABT-450 is being developed by AbbVie for use in combination with AbbVie's other investigational medicines for the treatment of HCV.

About the Hepatitis C Virus
Across the world, about 160 million people are chronically infected with hepatitis C.[1] Hepatitis C is an inflammation of the liver caused by an infection with the hepatitis C virus (HCV).[2] HCV is transmitted when an infected person's blood enters the bloodstream of another person.[3]

For the hepatitis C virus, there are six major HCV genotypes (GT1-6).[4] Presently, there is no vaccine for the hepatitis C virus (HCV) infection.3 Decision to treat is dependent on a number of factors such as the amount of liver damage present, other conditions the patient may have, amount of virus in the body, and viral genotype.4 If treatment is needed, a hepatitis C infection is typically treated with a combination of antivirals.3

About AbbVie
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. With its 125-year history, the company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2013, AbbVie employs approximately 21,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie<
'/>"/>

SOURCE AbbVie Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. AbbVie and Galapagos to Co-Develop Cystic Fibrosis Therapies
2. Strong Sales and Healthcare Reforms Benefit Earnings - Research Report on Gilead, Pfizer, Merck, AbbVie, and LifePoint
3. After Reviewing Brief Product Profiles, Surveyed Physicians Believe that Likely Candidates for Late-Phase Chronic Kidney Disease Products from AbbVie, Mitsubishi Tanabe, Eli Lilly, Concert, Fibrogen and Pfizer are Typically Stage 3b and 4 Patients
4. AbbVie Declares Quarterly Dividend
5. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
6. For Treating Psoriatic Arthritis, Clinical Data and Thought Leaders Opinions Indicate that AbbVie/Eisais Humira Has the Best Clinical Profile Among Key Marketed Therapies
7. AbbVie to Participate in 2013 Jeffries Global Healthcare Conference
8. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
9. AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohns Disease
10. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
11. AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)...   Regulus Therapeutics Inc . (NASDAQ: ... development of innovative medicines targeting microRNAs, today announced that ... of Regulus, will present a company overview at the ... the New York Palace Hotel on Wednesday, December 3, ... webcast at the time of the presentation and can ...
(Date:11/26/2014)... 26, 2014  BioScrip ® , Inc. (NASDAQ: BIOS ... Chief Executive Officer, will present at the Bank of America Merrill ... , , Date: , , , Wednesday, December 3, 2014 , ... , , , , Location: , , , Boca Raton ... BioScrip, Inc. BioScrip, Inc. is a leading ...
(Date:11/26/2014)... The medical magnetic resonance imaging (MRI) ... with world market revenues for 2013 at $5.1 ... types of medical imaging have led to improvements ... conditions in children and adults, each imaging procedure ... Medical Imaging Markets , analyzes the current and ...
Breaking Medicine Technology:Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 2Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 3Kalorama: Steady Growth in the Medical MRI Market 2Kalorama: Steady Growth in the Medical MRI Market 3
... , , ... that it will provide H1N1 flu vaccinations at select ... beginning Tuesday, December 29. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090129/NE64371LOGO ... everyone to get an H1N1 flu vaccine. Massachusetts, ...
... , , , SEATTLE, Dec. 28 Cell Therapeutics, Inc. (CTI) ... CTI,s Board of Directors (the "Board of Directors") approved and adopted ... stock purchase right will be distributed for each common share held ... the rights are not exercisable, and are attached to and trade ...
Cached Medicine Technology:CVS/pharmacy to Provide H1N1 Vaccinations in Massachusetts, Virginia and Orange County, California 2Cell Therapeutics, Inc. Adopts Shareholder Rights Plan 2Cell Therapeutics, Inc. Adopts Shareholder Rights Plan 3Cell Therapeutics, Inc. Adopts Shareholder Rights Plan 4
(Date:11/27/2014)... (PRWEB) November 27, 2014 In ... individuals allot to sleep has lessened, and due ... laptops, the quality of sleep has eroded. According ... asleep on the job (Reference: http://www.webmd.com/sleep-disorders/features/sleep-deprivation-workplace ). ... productivity index by an incalculable amount, leading not ...
(Date:11/27/2014)... HealthDay Reporter , WEDNESDAY, Nov. ... to acquire a second language, new research suggests. But anyone ... gain a brain boost, the small study finds. ... study co-author Ping Li, co-director of the Center for Brain, ... more interesting, Li said, that "the brain networks of the ...
(Date:11/27/2014)... The founders of VIM & VIGR, a ... functioning compression socks, are proud to announce the debut of ... Gradient Pressure (TM) knitting technology that is designed to increase ... commitment to adding flair and style to a product that ... the eye of a writer at The New York ...
(Date:11/27/2014)... VogueQueen.com is making every effort to offer ... world. As the premier online supplier of elegant special ... release a huge selection of sexy prom dresses today. ... also providing many beautiful styles in its product line. ... discounted prices. , “VogueQueen.com hopes to provide a truly ...
(Date:11/27/2014)... Dallas, Texas (PRWEB) November 27, 2014 ... research report on Global Insulin industry. For an ... including definition, classification, application, industry chain structure, industry ... report on global Insulin industry covers information ... manufacturing process, product cost structure and much more. ...
Breaking Medicine News(10 mins):Health News:Research Shows Surprising Number of US Workers Affected by Lack of Sleep 2Health News:Some People May Be Pre-Wired to Be Bilingual 2Health News:Some People May Be Pre-Wired to Be Bilingual 3Health News:VIM & VIGR Announces Launch of Men’s Line of Compression Socks 2Health News:A New Collection of Sexy Prom Dresses Has Been Released by the Reliable Online Supplier VogueQueen.com 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 3
... cancer gene can be turned on and off , MONDAY, ... becomes a bully while his peers are becoming thoughtful and ... their development that allows them to grow into cancerous tissue, ... researchers have identified a chemical process that turns off the ...
... of ... Fruit, ORLANDO, Fla., Jan. 7 ... drink healthier, adding Sun Shower(TM) 100%,Nectarine Juices into a diet may be the ... of Sun Shower(TM) Nectarine Juices are,tremendous," said Chris New, founder, chairman and CEO ...
... DAVID,S, Bermuda, Jan. 7 Warner Chilcott,Limited (Nasdaq: ... present at the 26th,Annual JPMorgan Healthcare Conference on ... Time. Presenting for Warner Chilcott will be Paul,Herendeen, ... Warner Chilcott,s presentation will be webcast live for ...
... in Spanish . , A group of scientists ... and Molecular Biology at Universitat Autnoma de Barcelona, has published ... large quantities only in lung cancers, particularly those caused by ... not yet developed and lesions are precancerous. Thus this molecule ...
... trend, but reasons aren,t clear , , MONDAY, Jan. 7 (HealthDay ... risk of prostate cancer compared to those who forego the ... looked at all men born in Denmark between 1935 and ... lower incidence of prostate cancer than fathers did. , The ...
... 7 CoolTouch Inc., a pioneering,manufacturer of medical lasers, ... an additional 510(K) clearance from the U.S. Food,and Drug ... laser is designed to ablate fat in areas such ... of conventional liposuction in larger areas,such as the abdomen ...
Cached Medicine News:Health News:Some Immature Brain Cells May Promote Tumors 2Health News:Start Your Day the Sun Shower(TM) Way 2Health News:UAB research could improve the prognosis and treatment of lung cancer 2Health News:Fatherhood Tied to Higher Prostate Cancer Risk 2Health News:Fatherhood Tied to Higher Prostate Cancer Risk 3Health News:CoolTouch Introduces CoolLipo(TM) Laser System, Recently FDA Cleared for Laser-Assisted Lipolysis 2
... of controlled compression and cold, the Shoulder ... anatomically designed cuff provides complete shoulder coverage ... ordered with an extra long strap (12AXL) ... can be ordered as a single cuff, ...
... FUNCTIONAL ARM BRACE (FAB) was designed ... to make it useful as a ... ,Far more than an "Elbow ROM ... over forearm rotation (pronation and supination)., ...
... splint features a completely padded posterior ... designed to provide passive flexion to ... fasciitis or Achilles tendonitis. Its ... order left or right. A ...
Designed for forefoot relief and healing. This shoe has a unique wedge outsole and a soft nylon upper. We also added the hi-top upper to keep the foot held back and reduce slippage. Available in five...
Medicine Products: